AzTrials
AzTrials

Chronic Low-back PainNCT04664348

Does Low Back Position Matters in Manual Therapy Treatment

A study testing Posteroanterior mobilization (neutral) and Posteroanterior mobilization (extension) in people with Chronic Low-back Pain, run by University of Jaén at 1 site in Spain.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The study will be carried out at the Faculty of Nursing and Physiotherapy of the University of Alcalá. The study has been approved by the Animal Research and Experimentation Ethics Committee of the University of Alcalá. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Chronic Low-back Pain
What is being tested?
Posteroanterior mobilization (neutral) and Posteroanterior mobilization (extension)
Could I receive a placebo?
No, everyone receives an active treatment
How many people
53 participants
Where
1 siteSpain
Study dates
9 Dec 2020to 30 Apr 2021
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • subjects with unspecific low back pain of 3 or more months of evolution prior commencement of the intervention

Who cannot join

  • lumbar pain related to infectious diseases
  • fractures
  • oncological processes
  • women in gestation period.

Trial locations and contacts

1 site in 1 country.

Spain1 site
  • Adrián Cabañas

    Alcalá de Henares, Madrid, 28801

Other trials in Spain

About this study

Official title: Is the Positioning of the Lumbar Spine Relevant to the Manual Treatment of the Chronic Low Back Pain

The study will be carried out at the Faculty of Nursing and Physiotherapy of the University of Alcalá. The study has been approved by the Animal Research and Experimentation Ethics Committee of the University of Alcalá. A total of 46 subjects of legal age with non-specific chronic low back pain will be selected and randomized into two interventions.

The first group will receive lumbar posteroanterior mobilizations with the lumbar spine in extension and the second group will receive lumbar mobilizations with neutral position of the spine. Both groups will also receive a home exercise program for the lumbar spine.

Read more

The total duration of the treatments will be 6 weeks, with pre-treatment, at 3 weeks of the treatment, post-treatment evaluations at 6 weeks, with a follow-up after 1 month and with a follow-up after 3 months.

The objective will be to evaluate which of the two interventions is more effective in addressing disability variables (main variable), pressure pain threshold, pain location, pain intensity, quality of life, quality of sleep, depression and kinesiophobia.

Being tested
Posteroanterior mobilization (neutral), Posteroanterior mobilization (extension)

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Posteroanterior mobilization (neutral)Other

    Positioning of the patient: Prone position with the lumbar area uncovered.

    Positioning of the therapist: Stand to one side of the table at the pelvis of the patient.

    Explanation of the technique: The contact will be made with the hypothenar eminence on the spinous processes to be treated. The other hand of the physiotherapist will reinforce the grip to obtain greater stability and precision. It will proceed to carry out some posteroanterior pushes of the target vertebrae, in order to desensitize the chosen area. The force exerted and the speed of the technique will be controlled by the therapist. The technique will be finished when the participant let the therapist know when the pain is gone or when the patient no longer refer a decrease on its pain.

    Both groups: The patient will be provided with a list of exercises focused on improving resistance to mechanical load in the lumbar region. The completion of the exercise will be in the 6 weeks of the duration of the treatment.

  • Posteroanterior mobilization (extension)Other

    Positioning of the patient: Prone position with the lumbar area uncovered. The head of the stretcher will be raised upwards, placing progressively to extend the lumbar region, until the patient communicates the reproduction of its symptoms.

    Positioning of the therapist: Stand to one side of the table at the pelvis of the patient.

    Explanation of the technique: The contact will be made with the hypothenar eminence on the spinous processes to be treated. The other hand of the physiotherapist will reinforce the grip to obtain greater stability and precision. It will proceed to carry out some posteroanterior pushes of the target vertebrae, in order to desensitize the chosen area. The force exerted and the speed of the technique will be controlled by the therapist. The technique will be finished when the participant let the therapist know when the pain is gone or when the patient no longer refer a decrease on its pain.

Study groups in NCT04664348
Study groupRoleWhat they receive
Experimental: Posteroanterior lumbar mobilization (extension of the lumbar spine)ExperimentalNot described
Receives: Other: Posteroanterior mobilization (extension)
Experimental: Posteroanterior lumbar mobilization (lumbar spine in neutral positioning)ExperimentalNot described
Receives: Other: Posteroanterior mobilization (neutral)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Changes in Disability

    measured with the Oswestry Low Back Pain Disability Questionnaire. The interpretation of the scores of this scale varies from 0% to 100%.

    0% to 20%: minimal disability: The patient can cope with most living activities.

    21%-40%: moderate disability 41%-60%: severe disability 61%-80%: crippled 81%-100%: These patients are either bed-bound or exaggerating their symptoms.

    Measured: Baseline, 3 weeks, 6 weeks, 1 month and 3 months after intervention commencement

Secondary outcomes (8)
  1. Changes in Pressure pain threshold

    measured with a Wagner brand Force Dial with a 1 cm2 rubber disc at the end of the device.

    Measured: Baseline, 3 weeks and 6 weeks after intervention commencement

  2. Changes in Site of pain

    measured with the body pain map

    Measured: Baseline, 3 weeks, 6 weeks, 1 month and 3 months after intervention commencement

  3. Pain measured with visual analogic scale

    A straight horizontal line of fixed length, usually 100 mm is drawn. The ends are defined as the extreme limits of the parameter to be measured (pain) orientated from the left (worst) to the right (best).

    Measured: Baseline, 3 weeks, 6 weeks, 1 month and 3 months after intervention commencement

  4. Health measured with the short form health survey version II

    It consists of 12 items from the 8 dimensions of the short form health survey 36: Physical Function, Function Social, Physical role, Emotional role, Mental health, Vitality, Body pain , General Health. For each of the 8 dimensions, the items are coded, aggregated and transformed into a scale that ranges from 0 (the worst state of health for that dimension) to 100 (the best state of health).

    Measured: Baseline, 3 weeks, 6 weeks, 1 month and 3 months after intervention commencement

  5. Quality of sleep measured with the Pittsburgh Sleep Quality Index

    In scoring the Pittsburgh Sleep Quality Index, seven component scores are derived, each scored 0 (no difficulty) to 3 (severe difficulty). The component scores are summed to produce a global score (range 0 to 21). Higher scores indicate worse sleep quality.

    Measured: Baseline, 3 weeks, 6 weeks, 1 month and 3 months after intervention commencement

  6. Depression measured with Beck's Depression Inventory

    When the test is scored, a value of 0 to 3 is assigned for each answer and then the total score is compared to a key to determine the depression's severity. The standard cut-off scores were as follows:

    0-9: indicates minimal depression 10-18: indicates mild depression 19-29: indicates moderate depression 30-63: indicates severe depression.

    Higher total scores indicate more severe depressive symptoms.

    Measured: Baseline, 3 weeks, 6 weeks, 1 month and 3 months after intervention commencement

  7. Kinesiophobia measured with the TAMPA scale of kinesiophobia

    The total score ranges between 17 and 68. A high value on the TAMPA scale of kinesiophobia indicates a high degree of kinesiophobia.

    Cutoff score developed by Vlaeyen:

    • score of 37 or over is considered as high
    • scores below 37 is considered as low)

    Measured: Baseline, 3 weeks, 6 weeks, 1 month and 3 months after intervention commencement

  8. Changes in Medication

    The patient will be asked about how many days a week they have needed to take medication

    Measured: Baseline, 3 weeks, 6 weeks, 1 month and 3 months after intervention commencement

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted11 Dec 2020
  2. Study start9 Dec 2020
  3. Primary completion31 Jan 2021
  4. Study completion30 Apr 2021

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
53 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04664348
Sponsor's protocol ID
CEIM/HU/2020/42
Status last verified
Jun 2021
First submitted
5 Dec 2020
Last updated
10 Jun 2021
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Posteroanterior mobilization (neutral) and Posteroanterior mobilization (extension) in people with Chronic Low-back Pain, run by University of Jaén at 1 site in Spain.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 10 Jun 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Spain. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Changes in Disability (time frame: Baseline, 3 weeks, 6 weeks, 1 month and 3 months after intervention commencement). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 Jun 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in